Inflammation has remained during evolution for a good reason: it helps combating pathogens, opposing tissue injury, and healing wounds. However, in some scenarios, inflammation cannot resolve and exerts detrimental effects on human health. The list of tissues and systems adversely affected by inflammation continues to lengthen and includes the nervous system, the vasculature, metabolism, and tumors.
This Symposium leads off with a session on acute inflammation and its resolution or development into chronic inflammation. Subsequent sessions focus on the impact of inflammation on cardiovascular metabolism, nervous system, and cancer. A final session is centered on the pharmacological control of inflammation resolution.
Other conferences are focused on a single inflammatory condition (one tissue, one organ): at variance with this, this Symposium program brings together experts that will discuss side by side different types of inflammation with different technical approaches and competences.
This Symposium will be therefore of interest to a wide range of scientists: immunologists, neuroscientists, those working on diseases including diabetes, cancer, autoimmunity, neurological disorders, stroke and atherosclerosis.
Many biotechnology and pharmaceutical companies are developing therapies to interfere with proinflammatory cytokines and their receptors and/or with cytokine signaling pathways. Some speakers from these companies will be present to describe how basic science can develop into translational results.
Using Elsevier's new MIAM2016 app, you can browse the scientific programme by days, topic or speaker, create your own personal programme, locate rooms and exhibitor stands on the floor plans, and more. Before first use, you will need to download the latest conference data and then afterwards, you can use the app offline.
- December 16, 2015 Initial release